Altre lingue ContraFect Corporation

Azioni

CFRX.Q

US2123264093

Mercato chiuso - OTC Markets Altri mercati azionari 19:56:45 23/04/2024			Variaz. 5gg	Var. 1 gen.
0,0191 ^USD	+6,00%		-11,57%	-36,33%

2023	ContraFect Corporation annuncia le dimissioni della dirigenza	CI
2023	ContraFect Corporation annuncia le dimissioni di Michael Messinger da Amministratore delegato	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Stock Futures -2-	19/04
North American Morning Briefing : Big Banks Kick -2-	12/04
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	05/04
Bidding Procedure Approved for ContraFect Corporation	09/02
Motion for Asset Sale Filed by ContraFect Corporation	12/01
ContraFect Corporation Announces Resignation of Michael Messinger as Chief Financial Officer	05/12
ContraFect Corporation Announces Management Resignations	05/12
ContraFect Corporation Announces Resignation of Michael Messinger as Chief Executive Officer	05/12
ContraFect Corporation Filed for Bankruptcy	04/12
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	20/11
ContraFect Corporation Announces Chief Executive Officer Changes	15/11
ContraFect Corporation Announces Executive Changes	15/11
ContraFect Corporation Appoints Michael Messinger as Chief Financial Officer	15/11
ContraFect Corporation Implements Restructuring Plan Resulting in Reduction to Workforce from A Total of 23 Employees to Five Employee	15/11
ContraFect: Q3 Earnings Snapshot	14/11
ContraFect Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
North American Morning Briefing : Stock Futures Dip as Inflation Data Looms	13/11
ContraFect Corporation(OTCPK:CFRX) dropped from S&P TMI Index	13/11
ContraFect Corporation(OTCPK:CFRX) dropped from NASDAQ Composite Index	08/11
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study	16/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ContraFect Corporation

Azioni

CFRX.Q

US2123264093

Altre lingue

Filtri